Wells Fargo’s GeneDx Holdings Warrant WGSWW Stock Holding History

Wells Fargo’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18	Sell	2,200 -166	-7%	-$3	﹤0.01%	6831
2025 Q4	$112	Hold	2,366	–	–	﹤0.01%	6421
2025 Q3	$259	Buy	2,366 +166	+8%	+$14	﹤0.01%	6330
2025 Q2	$159	Hold	2,200	–	–	﹤0.01%	6453
2025 Q1	$462	Hold	2,200	–	–	﹤0.01%	6272
2024 Q4	$352	Hold	2,200	–	–	﹤0.01%	6330
2024 Q3	$165	Hold	2,200	–	–	﹤0.01%	6240
2024 Q2	$65	Hold	2,200	–	–	﹤0.01%	6284
2024 Q1	$121	Hold	2,200	–	–	﹤0.01%	6610
2023 Q4	$22	Hold	2,200	–	–	﹤0.01%	7188
2023 Q3	$66	Hold	2,200	–	–	﹤0.01%	6859
2023 Q2	$23	Hold	2,200	–	–	﹤0.01%	7276
2023 Q1	$41	Hold	2,200	–	–	﹤0.01%	7168
2022 Q4	$42	Hold	2,200	–	–	﹤0.01%	7073
2022 Q3	$0	Hold	2,200	–	–	﹤0.01%	7469
2022 Q2	$1K	Hold	2,200	–	–	﹤0.01%	6631
2022 Q1	$2K	Hold	2,200	–	–	﹤0.01%	6706
2021 Q4	$2K	Hold	2,200	–	–	﹤0.01%	6917
2021 Q3	$5K	Hold	2,200	–	–	﹤0.01%	6391
2021 Q2	$10K	Buy	2,200 +200	+10%	+$856	﹤0.01%	6152
2021 Q1	$10K	Buy	+2,000	New	+$11.1K	﹤0.01%	6352

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wells Fargo's WGSWW Position: Q1 2026 in Review

Wells Fargo reduced its GeneDx Holdings Warrant (WGSWW) stake by 7% in Q1 2026, selling an estimated $3 and leaving 2,200 shares worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #6831.

Wells Fargo first reported a position in WGSWW in Q1 2021 and has held it in 21 quarters since. The position peaked at $10K in Q2 2021. 13 funds tracked by Wall St. Rank hold WGSWW as of Q1 2026.

Wells Fargo held 2,200 shares of GeneDx Holdings Warrant worth $18 as of Q1 2026.
Wells Fargo sold 166 GeneDx Holdings Warrant shares in Q1 2026, an estimated $3.
GeneDx Holdings Warrant made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6831 holding.
Wells Fargo first reported a position in GeneDx Holdings Warrant in Q1 2021 and has held it in 21 quarters since.
Wells Fargo's GeneDx Holdings Warrant position peaked at $10K in Q2 2021.
13 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.